cetrelimab,erdafitinib,infigratinib
bridgebio pharmaceutical,janssen
['advanced uc', 'proof302', ' uc,(-ucsd),(-ucsf),', 'erdafitinib', 'norse']
great news &amp; presentation by leading to level i evidence with erdafitinib in pts with advanced uc with fgfr2/3 activating mutation/fusion! interested to also see norse trial data &amp; our genomic data from proof302 #asco23 
Oncologist, Professor, clinical/translational research, Genitourinary Cancers, bladder, prostate, testis, Univ of Washington, Fred Hutch; views are mine